SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-09-000122
Filing Date
2009-01-02
Accepted
2009-01-02 16:47:51
Documents
4
Period of Report
2008-12-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v136097_8k.htm 8-K 47283
2 v136097_ex10-1.htm EX-10.1 65566
3 v136097_ex99-1.htm EX-99.1 9426
4 GRAPHIC logo.jpg GRAPHIC 1648
  Complete submission text file 0001144204-09-000122.txt   126617
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 09501961
SIC: 2834 Pharmaceutical Preparations